Transaction · 0001936799-26-000002

Sumner Michael John

Sumner Michael John, CMO, reported a transaction classified as withholding at INOVIO PHARMACEUTICALS, INC. involving 3903.000000 shares for an estimated $6986.37. Reported holdings after the transaction were 30507.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FCMO
INOINOVIO PHARMACEUTICALS, INC.
Filing timeFeb 27
Trade dateFeb 26, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.81
Pre-filing
1mo ago -15.5%1w ago -5.0%1d ago +2.2%
Returns since
7d -3.9%30d -11.0%90d -28.2%180d -29.8%1y

INO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
INO since 2026-02-27Filed 212 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001936799-26-000002
Common Stock
Transaction date
Feb 26, 2026
Filed Feb 27, 2026, 12:00 AM · 1d delay
Shares
3.90k sh
$1.79 per share
Estimated value
-$6.98k
Computed from shares × price
Holdings after
30.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows:…

  2. F2

    Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows:…

  3. F3

    The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricte…

Original filing · 0001936799-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

INO